Europe Startup Funding Rounds

Stationary battery storage systems made with repurposed electric-vehicle batteries for commercial buildings, industry and charging operators.

Gravity Gardens develops a dry seed-activation treatment intended to help crops establish and withstand stress without chemical coatings or pre-soaking.

Gaia Tech develops upcycled functional ingredients for cosmetics, food and nutraceutical manufacturers. It analyzes agricultural side streams such as olive pomace, rapeseed meal and spent coffee grounds, extracts valuable compounds, then formulates and validates standardized ingredients that can be incorporated into customer products.

Limetax combines a network of tax advisory firms with its own DATEV-based AI platform and central services that help German tax firms automate routine work and scale client advice.

SCI Semiconductor develops ICENI, a family of microcontrollers that enforce memory safety and software compartmentalisation in hardware. Embedded-systems developers can build security-critical devices on the chips; hardware-enforced capability boundaries isolate components and constrain what code can access if a software flaw is exploited.

A Berlin aviation startup developing a more efficient flying-wing aircraft platform, beginning with a two-seat ultralight for private pilots and flight schools.

Implicity provides AI-powered remote cardiac monitoring and data-management software that helps care teams interpret information from implanted heart devices.

HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets.

MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers.

Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation.